No EUA For COVID-19 Vaccines Prior To Trials Completion, Says India

Russia To Conduct Phase III Trials In India

The Indian regulator says it is not considering emergency use authorization for COVID-19 vaccines before completion of clinical trials, a stand validated by AstraZeneca halting trials of its vaccine candidate due to an adverse event in UK. Meanwhile, India has signed up for Phase III trials of Russia’s vaccine candidate

Blue Planet Studio/Shutterstock.com
COVID-19 Vaccines Have Seen Regulator Stance Across The World Differ • Source: Shutterstock

More from COVID-19

More from Scrip